This episode of CU Anschutz 360 focuses on a promising breakthrough therapy for patients with large B-cell lymphoma, an aggressive subtype of the disease. The clinical trial was led by Manali Kamdar, MD, clinical director of the lymphoma program in the Division of Hematology at the University of Colorado School of Medicine.
Even though it comes with such coveted benefits as better sleep, sharper minds and stronger bodies, convincing people to move has been the bane of public health workers for decades. Things like desk jobs, drive-throughs, […]
Vice Chancellor for Research Thomas Flaig, MD, delivered the annual State of Research Address on Dec. 6 to an online audience of more than 500 scientists, students and staff from the University of Colorado Anschutz […]
NASHVILLE, Tenn., May 17, 2023 /PRNewswire/ — Healing Innovations, Inc., the creators of the groundbreaking Rise&Walk® technology, is proud to announce its successful partnership with NeuAbility, a leading rehabilitation center in Denver, Colorado. This collaboration […]
Copyright © 2026 Biotech Networks
